Tucker Asset Management LLC Amphastar Pharmaceuticals, Inc. Transaction History

Tucker Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Mar 04, 2024	SELL	$44.49 - $62.93 $44,223 - $62,552	-994 Reduced 3.43%	27,956 $1.73 Billion
Q3 2023 Dec 04, 2023	BUY	$45.51 - $65.0 $52,245 - $74,620	1,148 Added 4.13%	28,950 $1.33 Billion
Q2 2023 Sep 08, 2023	SELL	$35.77 - $58.38 $138,429 - $225,930	-3,870 Reduced 12.22%	27,802 $1.6 Billion
Q1 2023 May 11, 2023	BUY	$27.99 - $37.92 $886,499 - $1.2 Million	31,672 New	31,672 $1.19 Billion

286

34.9M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Tucker Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tucker Asset Management LLC with notifications on news.